289 related articles for article (PubMed ID: 25326638)
1. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.
Gierada DS; Pinsky P; Nath H; Chiles C; Duan F; Aberle DR
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25326638
[TBL] [Abstract][Full Text] [Related]
2. Predicting Malignancy Risk of Screen-Detected Lung Nodules-Mean Diameter or Volume.
Tammemagi M; Ritchie AJ; Atkar-Khattra S; Dougherty B; Sanghera C; Mayo JR; Yuan R; Manos D; McWilliams AM; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Seely JM; Burrowes P; Bhatia R; Haider EA; Boylan C; Jacobs C; van Ginneken B; Tsao MS; Lam S;
J Thorac Oncol; 2019 Feb; 14(2):203-211. PubMed ID: 30368011
[TBL] [Abstract][Full Text] [Related]
3. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
[TBL] [Abstract][Full Text] [Related]
4. Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines.
van Riel SJ; Ciompi F; Jacobs C; Winkler Wille MM; Scholten ET; Naqibullah M; Lam S; Prokop M; Schaefer-Prokop C; van Ginneken B
Eur Radiol; 2017 Oct; 27(10):4019-4029. PubMed ID: 28293773
[TBL] [Abstract][Full Text] [Related]
5. Validation of a Deep Learning Algorithm for the Detection of Malignant Pulmonary Nodules in Chest Radiographs.
Yoo H; Kim KH; Singh R; Digumarthy SR; Kalra MK
JAMA Netw Open; 2020 Sep; 3(9):e2017135. PubMed ID: 32970157
[TBL] [Abstract][Full Text] [Related]
6. Nodule size and overdiagnosis in lung cancer CT screening.
Vannier MW
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25326639
[No Abstract] [Full Text] [Related]
7. Results of the two incidence screenings in the National Lung Screening Trial.
Aberle DR; DeMello S; Berg CD; Black WC; Brewer B; Church TR; Clingan KL; Duan F; Fagerstrom RM; Gareen IF; Gatsonis CA; Gierada DS; Jain A; Jones GC; Mahon I; Marcus PM; Rathmell JM; Sicks J;
N Engl J Med; 2013 Sep; 369(10):920-31. PubMed ID: 24004119
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
[TBL] [Abstract][Full Text] [Related]
9. Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
Yip R; Henschke CI; Xu DM; Li K; Jirapatnakul A; Yankelevitz DF
AJR Am J Roentgenol; 2017 May; 208(5):1011-1021. PubMed ID: 28245151
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
Maiga AW; Deppen SA; Mercaldo SF; Blume JD; Montgomery C; Vaszar LT; Williamson C; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Grogan EL
JAMA Surg; 2018 Apr; 153(4):329-334. PubMed ID: 29117314
[TBL] [Abstract][Full Text] [Related]
11. Probability of cancer in pulmonary nodules detected on first screening CT.
McWilliams A; Tammemagi MC; Mayo JR; Roberts H; Liu G; Soghrati K; Yasufuku K; Martel S; Laberge F; Gingras M; Atkar-Khattra S; Berg CD; Evans K; Finley R; Yee J; English J; Nasute P; Goffin J; Puksa S; Stewart L; Tsai S; Johnston MR; Manos D; Nicholas G; Goss GD; Seely JM; Amjadi K; Tremblay A; Burrowes P; MacEachern P; Bhatia R; Tsao MS; Lam S
N Engl J Med; 2013 Sep; 369(10):910-9. PubMed ID: 24004118
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations.
Zhao YR; van Ooijen PM; Dorrius MD; Heuvelmans M; de Bock GH; Vliegenthart R; Oudkerk M
Acta Radiol; 2014 Jul; 55(6):691-8. PubMed ID: 24132766
[TBL] [Abstract][Full Text] [Related]
13. Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening.
Heuvelmans MA; Walter JE; Vliegenthart R; van Ooijen PMA; De Bock GH; de Koning HJ; Oudkerk M
Thorax; 2018 Aug; 73(8):779-781. PubMed ID: 29056601
[TBL] [Abstract][Full Text] [Related]
14. External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data.
Winter A; Aberle DR; Hsu W
Thorax; 2019 Jun; 74(6):551-563. PubMed ID: 30898897
[TBL] [Abstract][Full Text] [Related]
15. Size and Growth Assessment of Pulmonary Nodules: Consequences of the Rounding.
Li K; Yip R; Avila R; Henschke CI; Yankelevitz DF
J Thorac Oncol; 2017 Apr; 12(4):657-662. PubMed ID: 28007625
[TBL] [Abstract][Full Text] [Related]
16. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals.
Heuvelmans MA; Oudkerk M; de Bock GH; de Koning HJ; Xie X; van Ooijen PM; Greuter MJ; de Jong PA; Groen HJ; Vliegenthart R
Eur Radiol; 2013 Jul; 23(7):1836-45. PubMed ID: 23508275
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.
Walter JE; Heuvelmans MA; de Bock GH; Yousaf-Khan U; Groen HJM; van der Aalst CM; Nackaerts K; van Ooijen PMA; de Koning HJ; Vliegenthart R; Oudkerk M
Lung Cancer; 2018 Nov; 125():103-108. PubMed ID: 30429006
[TBL] [Abstract][Full Text] [Related]
18. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
[TBL] [Abstract][Full Text] [Related]
19. Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants.
Gierada DS; Pinsky PF; Duan F; Garg K; Hart EM; Kazerooni EA; Nath H; Watts JR; Aberle DR
Eur Radiol; 2017 Aug; 27(8):3249-3256. PubMed ID: 28050695
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
